X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2527) 2527
Publication (187) 187
Book Review (65) 65
Book Chapter (52) 52
Conference Proceeding (26) 26
Patent (10) 10
Dissertation (3) 3
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1786) 1786
oncology (1455) 1455
female (1352) 1352
first-line therapy (903) 903
index medicus (882) 882
middle aged (878) 878
aged (827) 827
chemotherapy (739) 739
adult (735) 735
male (668) 668
antineoplastic combined chemotherapy protocols - therapeutic use (643) 643
breast neoplasms - drug therapy (635) 635
treatment outcome (634) 634
first-line treatment (464) 464
cancer (431) 431
postmenopausal women (427) 427
breast cancer (407) 407
first-line (354) 354
care and treatment (329) 329
antineoplastic combined chemotherapy protocols - adverse effects (325) 325
first-line chemotherapy (319) 319
breast neoplasms - pathology (307) 307
aged, 80 and over (289) 289
tamoxifen (280) 280
phase-iii (274) 274
therapy (272) 272
neoplasm metastasis (263) 263
disease-free survival (261) 261
randomized-trial (255) 255
antineoplastic agents - therapeutic use (254) 254
pharmacology & pharmacy (247) 247
paclitaxel (240) 240
double-blind (235) 235
neoplasm staging (235) 235
drug therapy (233) 233
trial (233) 233
metastasis (229) 229
anastrozole (228) 228
cisplatin (224) 224
lung neoplasms - drug therapy (220) 220
survival (219) 219
medicine & public health (211) 211
aromatase inhibitors (207) 207
phase-ii trial (207) 207
combination (206) 206
drug administration schedule (203) 203
efficacy (198) 198
prognosis (196) 196
survival analysis (196) 196
carcinoma (195) 195
docetaxel (195) 195
research (184) 184
carcinoma, non-small-cell lung - drug therapy (181) 181
antineoplastic agents, hormonal - therapeutic use (179) 179
deoxycytidine - analogs & derivatives (178) 178
fluorouracil - administration & dosage (177) 177
colorectal neoplasms - drug therapy (174) 174
hematology, oncology and palliative medicine (174) 174
clinical trials as topic (173) 173
megestrol-acetate (172) 172
fluorouracil (167) 167
clinical trials (165) 165
randomized trial (161) 161
analysis (160) 160
endocrine therapy (160) 160
oxaliplatin (157) 157
metastatic breast cancer (156) 156
survival rate (156) 156
carboplatin (155) 155
bevacizumab (153) 153
retrospective studies (152) 152
multicenter (150) 150
letrozole (149) 149
antineoplastic combined chemotherapy protocols - administration & dosage (148) 148
tamoxifen - therapeutic use (144) 144
deoxycytidine - administration & dosage (143) 143
phase-iii trial (142) 142
gemcitabine (141) 141
postmenopause (140) 140
health aspects (139) 139
randomized controlled trials as topic (139) 139
disease progression (135) 135
5-fluorouracil (133) 133
vinorelbine (133) 133
capecitabine (132) 132
colorectal cancer (130) 130
follow-up studies (130) 130
open-label (129) 129
paclitaxel - administration & dosage (127) 127
vinblastine - analogs & derivatives (127) 127
aromatase inhibitors - therapeutic use (126) 126
respiratory system (122) 122
irinotecan (118) 118
chemotherapy, adjuvant (117) 117
drug therapy, combination (116) 116
leucovorin (116) 116
first line (115) 115
breast neoplasms - metabolism (114) 114
vinblastine - administration & dosage (113) 113
cisplatin - administration & dosage (111) 111
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2447) 2447
German (72) 72
French (38) 38
Chinese (25) 25
Russian (13) 13
Korean (10) 10
Polish (6) 6
Hungarian (3) 3
Slovenian (2) 2
Spanish (2) 2
Indonesian (1) 1
Japanese (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European Journal of Cancer, ISSN 0959-8049, 05/2018, Volume 95, pp. 93 - 101
Journal Article
Journal Article
Journal Article
Gastric Cancer, ISSN 1436-3291, 1/2018, Volume 21, Issue 1, pp. 84 - 95
Journal Article
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 2/2014, Volume 143, Issue 3, pp. 459 - 467
Journal Article
Journal Article
European Journal of Internal Medicine, ISSN 0953-6205, 2016, Volume 32, pp. 84 - 90
Abstract Background Currently only a few studies compare sequential and concomitant non-bismuth Helicobacter pylori therapies referring to high antibiotic... 
Internal Medicine | H. pylori treatment | Sequential treatment | First line | Concomitant treatment | Metronidazole resistance | Clarithromycin resistance | 14-DAY TRIPLE | 1ST-LINE TREATMENT | MULTICENTER | METAANALYSIS | REGIMEN | STANDARD TRIPLE THERAPY | RATES | MEDICINE, GENERAL & INTERNAL | INFECTION | HYBRID THERAPY | DURATION | Esomeprazole - administration & dosage | Humans | Middle Aged | Carbon Isotopes | Drug Resistance, Bacterial | Male | Helicobacter Infections - pathology | Helicobacter pylori | Peptic Ulcer - microbiology | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Adult | Female | Helicobacter Infections - metabolism | Urea - metabolism | Amoxicillin - administration & dosage | Drug Therapy, Combination | Dyspepsia - drug therapy | Metronidazole - administration & dosage | Breath Tests | Dyspepsia - microbiology | Pyloric Antrum - pathology | Biopsy | Aged | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Clinical trials | Drug resistance in microorganisms | Clarithromycin | Helicobacter Infections/drug therapy | Peptic Ulcer/drug therapy | Proton Pump Inhibitors/administration & dosage | Helicobacter Infections/pathology | Peptic Ulcer/microbiology | Tissues and Organs | Life Sciences | Esomeprazole/administration & dosage | Hépatology and Gastroenterology | Pyloric Antrum/pathology | Anti-Bacterial Agents/administration & dosage | Dyspepsia/microbiology | Helicobacter Infections/metabolism | Bacteriology | Clarithromycin/administration & dosage | Urea/metabolism | Metronidazole/administration & dosage | Microbiology and Parasitology | Human health and pathology | Amoxicillin/administration & dosage | Dyspepsia/drug therapy
Journal Article
British Journal of Haematology, ISSN 0007-1048, 2001, Volume 115, Issue 2, pp. 272 - 278
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2012, Volume 367, Issue 5, pp. 435 - 444
The combination of anastrozole and fulvestrant — which interfere with estrogen signaling by distinct mechanisms — increases progression-free and overall... 
PHASE-III TRIAL | MEDICINE, GENERAL & INTERNAL | ONCOLOGY-GROUP | TAMOXIFEN | DOUBLE-BLIND | RANDOMIZED-TRIAL | ENDOCRINE THERAPY | POSTMENOPAUSAL WOMEN | 1ST-LINE THERAPY | HORMONAL-THERAPY | FIRST-LINE THERAPY | Triazoles - administration & dosage | Triazoles - adverse effects | Estradiol - analogs & derivatives | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Nitriles - administration & dosage | Aromatase Inhibitors - adverse effects | Neoplasm Metastasis | Aged, 80 and over | Estradiol - adverse effects | Postmenopause | Adult | Female | Aromatase Inhibitors - administration & dosage | Estradiol - administration & dosage | Kaplan-Meier Estimate | Breast Neoplasms - drug therapy | Cross-Over Studies | Disease-Free Survival | Estrogen Antagonists - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Estrogen Antagonists - adverse effects | Breast Neoplasms - mortality | Aged | Nitriles - adverse effects | Drugs | Dose-response relationship (Biochemistry) | Usage | Patient outcomes | Breast cancer | Dosage and administration | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | Fulvestrant | Statistical analysis | Anastrozole | Estrogen receptors | Tamoxifen | Cancer therapies | Survival | Patients | Post-menopause | Metastases | Chemotherapy | Womens health | Aromatase | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article